Financial Tearsheet

Cronos Group is an innovative global cannabinoid company with international production and distribution networks across five continents. The Company is committed to building disruptive intellectual property and establishing an iconic brand portfolio.

Stock Chart

Stock Chart

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases

24 Jun 22
Cronos Group Inc. Announces Results of 2022 Annual Meeting of Shareholders
TORONTO, June 24, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders held on June 23, 2022 (the “Meeting”) shareholders voting in person or by proxy held in total 265,763,587 common shares of the
21 Jun 22
Cronos Group and Ginkgo Bioworks Announce Achievement of THCV Equity Milestone
TORONTO and BOSTON, June 21, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos"), an innovative global cannabinoid company, and Ginkgo Bioworks (NYSE: DNA) (“Ginkgo”), the leading horizontal platform for cell programming, today announced the achievement of the third
10 May 22
Cronos Group Inc. Announces Conference Participation for May 2022
TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and Chief Executive Office, will speak at two upcoming conferences: Canaccord

SEC Filings

Filing date Description

Report of unscheduled material events or corporate event

Specialized Disclosure Report

Statement of changes in beneficial ownership of securities


22 January 2021 at 4:10 PM EST
Cronos Group at the 24th Annual CIBC Western Institutional Investor Conference
16 December 2020 at 12:30 PM EST
The Road Ahead, Preparation for 2021: MKM Partners Virtual Conference
17 November 2020 at 1:10 PM EST
Jefferies Virtual West Coast Consumer Conference